liposomal doxorubicin
Drug timelines are a Plus or Pro feature.
42 regulatory and trial events tracked for liposomal doxorubicin, covering 2006-11-08 to 2025-08-13. Get the full timeline:
Most recent: Clinical Trial Update: Breast Cancer Risk Investigation in Grown-up Hodgkin Lymphoma Patients Treated With MBVD. Multicenter Retrospective Study on ≥200 Adult Female HL Patients Treated With ≥1 MBVD Cycle (NPLD, Bleomycin, Vinblastine, Dacarbazine). It Investigates Breast Cancer Incidence Post-treatment.